Ocaliva with Liver CirrhosisResearch Question:
Does Ocaliva improve health outcomes in people with liver cirrhosis?
Basic Study Information
Purpose:Location: Strong Memorial Hospital
Study participation is a minimum of 1 year, with up to 2 full years of participation
possible. Subjects will be randomized to take either 10mg or 25mg of Ocaliva or placebo
pill once daily. Subjects must come into the clinic for study related procedures a
minimum of 10 times. A liver biopsy is required.
Study Reference #: 20170813
Lead Researcher (Principal Investigator)
Lead Researcher: Jonathan Huang
Study Contact InformationStudy Coordinator: Lauren Ott
Phone: (585) 276-3042
Additional Study Details
Sponsored by Intercept Pharmaceuticals
Number of Visits:
More than 10
Trial Not Found
The study you are looking for is not active at this time.
Return to Search